In the field of preclinical and basic drug discovery research, our service involves three-dimensional imaging and subsequent analysis of mouse organs, organoids, and human biopsy samples. We provide precise data quickly, including pharmacokinetics and toxicity assessments. In Japan, seven out of ten major pharmaceutical companies utilize our service for pharmacokinetic and toxicity evaluations. By upgrading the evaluation and analysis process from traditional 2D approaches to more accurate and efficient 3D methods, researchers in the pharmaceutical industry can enhance the precision of drug candidate assessments and reduce drug development timelines significantly.
JP
